hemedic ApS — Credit Rating and Financial Key Figures
CVR number: 36708492
Byskellet 9, 2960 Rungsted Kyst
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 652.66 | 752.87 | 612.79 | 727.43 | 2 175.87 |
| Employee benefit expenses | - 493.97 | - 526.76 | - 616.15 | - 686.99 | -1 101.95 |
| Total depreciation | -18.67 | -32.00 | -32.00 | -77.33 | |
| EBIT | 158.69 | 207.45 | -35.36 | 8.44 | 996.58 |
| Other financial income | 8.55 | 7.15 | 2.00 | 5.68 | 7.19 |
| Other financial expenses | -18.32 | -20.03 | -30.90 | -35.09 | -26.38 |
| Pre-tax profit | 148.93 | 194.57 | -64.26 | -20.98 | 977.39 |
| Income taxes | -40.83 | -48.72 | 8.18 | -0.93 | - 230.52 |
| Net earnings | 108.10 | 145.86 | -56.08 | -21.91 | 746.87 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 141.33 | 109.33 | 77.33 | ||
| Tangible assets total | 141.33 | 109.33 | 77.33 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 127.78 | 117.08 | 179.85 | 385.78 | 927.08 |
| Inventories total | 127.78 | 117.08 | 179.85 | 385.78 | 927.08 |
| Current trade debtors | 34.18 | 85.10 | 353.92 | 555.78 | 996.84 |
| Prepayments and accrued income | 2.64 | 2.64 | 60.17 | 7.23 | |
| Current other receivables | 31.42 | ||||
| Current deferred tax assets | 47.51 | 2.56 | 11.14 | ||
| Short term receivables total | 34.18 | 87.74 | 404.07 | 649.93 | 1 015.21 |
| Cash and bank deposits | 883.75 | 1 024.24 | 944.23 | 859.39 | 1 943.04 |
| Cash and cash equivalents | 883.75 | 1 024.24 | 944.23 | 859.39 | 1 943.04 |
| Balance sheet total (assets) | 1 045.71 | 1 370.40 | 1 637.48 | 1 972.44 | 3 885.32 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 410.09 | 518.19 | 664.04 | 607.97 | 586.06 |
| Profit of the financial year | 108.10 | 145.86 | -56.08 | -21.91 | 746.87 |
| Shareholders equity total | 568.19 | 714.04 | 657.97 | 636.06 | 1 382.93 |
| Provisions | 4.69 | ||||
| Non-current trade creditors | 588.49 | 1 782.84 | |||
| Non-current owed to group member | 383.03 | 14.21 | |||
| Non-current liabilities total | 971.52 | 1 797.06 | |||
| Current loans from credit institutions | 0.10 | 5.99 | 1.64 | 8.92 | |
| Current trade creditors | 24.00 | 12.77 | 270.30 | ||
| Current owed to group member | 260.00 | 311.45 | 368.25 | ||
| Short-term deferred tax liabilities | 40.83 | 44.02 | 44.02 | 239.10 | |
| Other non-interest bearing current liabilities | 152.59 | 277.44 | 295.31 | 355.94 | 466.24 |
| Current liabilities total | 477.52 | 651.66 | 979.52 | 364.86 | 705.34 |
| Balance sheet total (liabilities) | 1 045.71 | 1 370.40 | 1 637.48 | 1 972.44 | 3 885.32 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.